How to cite item

Comments on “Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: the phase III DECISION trial”

   
@article{CCO3491,
	author = {Martin Schlumberger},
	title = {Comments on “Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: the phase III DECISION trial”},
	journal = {Chinese Clinical Oncology},
	volume = {3},
	number = {1},
	year = {2014},
	keywords = {},
	abstract = {Patients with locally advanced or metastatic differentiated thyroid cancer (DTC) that is radioactive iodine (RAI)- refractory and progressive have a poor prognosis due to the lack of effective treatment options. Several phase 2 trials have shown that some tyrosine kinase inhibitors with antiangiogenic effects are able to induce tumor responses in some patients, but there is yet no demonstration in a phase 3 trial that they may prolong progression free survival.},
	issn = {2304-3873},	url = {https://cco.amegroups.org/article/view/3491}
}